Sign In
Buy OMER
$10.48
+0.150 (+1.45%)
At Close: Jun 23, 2026
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
10:39am, Monday, 22'nd Jun 2026
Both companies target serious health challenges, but their financials and risk profiles reveal sharply different paths for growth-focused investors.
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
11:02am, Saturday, 20'th Jun 2026
Intellia Therapeutics is leveraging its strategic partnership with Regeneron to advance a deep pipeline of CRISPR-based gene editing therapies. Omeros recently entered the commercial stage with the FD
Omeros Announces Webcast Details for Annual Meeting of Shareholders
08:30am, Monday, 15'th Jun 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, J
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now
10:56am, Thursday, 04'th Jun 2026
Omeros (OMER) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall St
Omeros Q1 Earnings Call Highlights
12:15am, Thursday, 14'th May 2026
Omeros NASDAQ: OMER reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic s
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
11:20pm, Wednesday, 13'th May 2026
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
Omeros Corporation Reports First Quarter 2026 Financial Results
04:02pm, Wednesday, 13'th May 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include: F
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
04:02pm, Monday, 11'th May 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros ma
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
01:02pm, Monday, 27'th Apr 2026
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade
10:55am, Monday, 27'th Apr 2026
The consensus price target hints at a 222.8% upside potential for Omeros (OMER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
4 Medical Product Stocks to Buy From a Challenging Industry
09:31am, Monday, 27'th Apr 2026
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
08:45am, Thursday, 16'th Apr 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent Healthcare Common Procedure Coding Sys
Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of “Moderate Buy” by Brokerages
03:20am, Sunday, 12'th Apr 2026
Omeros Corporation (NASDAQ: OMER - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst h
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
10:56am, Friday, 10'th Apr 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 266.7% in Omeros (OMER). While the effectiveness of this highly sought-after metric is questionable, the positi
JPMorgan Chase & Co. Boosts Holdings in Omeros Corporation $OMER
04:44am, Wednesday, 08'th Apr 2026
JPMorgan Chase and Co. grew its position in Omeros Corporation (NASDAQ: OMER) by 1,201.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
